期刊文献+

NF2基因甲基化及其mRNA表达与乳腺癌发病的关系(英文) 被引量:3

Methylation and the mRNA Expression of NF2 and their association with the Morbidity of Breast Cancer
原文传递
导出
摘要 目的:探讨乳腺癌中NF2基因启动子甲基化状态及其mRNA水平与乳腺癌发病的关系。方法:应用甲基化特异性聚合酶链反应(MSP)和逆转录-聚合酶链反应(RT-PCR)技术,检测47例乳腺癌组织及相应的癌旁组织和15例乳腺良性病变组织,分析NF2基因的甲基化与某些临床参数及mRNA表达的关系。结果:NF2基因启动子区在乳腺癌、癌旁和乳腺良性病变组织中的甲基化频率分别为57.4%(27/47)、23.4%(23/47)和0%(0/15),且乳腺癌组明显高于其余两组(P<0.05)。NF2基因发生甲基化与发病年龄、组织分型、转移和组织分级无相关性。乳腺癌组NF2基因mRNA的相对表达量(0.16±0.11)明显低于相应的癌旁组(0.27±0.14)及乳腺良性病变组(0.64±0.17()P<0.05)。NF2基因启动子区甲基化频率与其mRNA表达呈负相关(Spearman’sr=-0.314,P<0.05)。结论:NF2基因发生甲基化与乳腺癌的发生密切相关,NF2mRNA表达与NF2基因启动子高甲基化呈负相关。 Objective:To investigate the frequency of promoter hypermethylation,the expression of neurofibromatosis type 2(NF2)gene and the association with breast cancers.Methods:Methylation-specific PCR was employed to detect methylation of NF2 in the 47 breast cancer tissues,peficaneerous tissues,and 15 benign breast lesions tissues.The mRNA expression of NF2 was determined by reverse transcription PCR in the aforesaid tissues.The relationship between methylation and mRNA expression of NF2 was analyzed.Results:The frequencies of NF2 promoter methylation were 57.4%(27/47),23.4(23/47)and 0%(0/15)in breast cancer tissues,peficaneerous and benign breast lesions tissues,respectively.NF2 methylation in breast cancer tissues increased significantly compared with the other two groups(P<0.05).No correlation was found between the methylation of NF2 and clinical features including age of onset,histological typing,lymphnode metastasis,and histological grade(P>0.05).The expression of NF2 in breast cancer tissues(0.16±0.11)and peficaneerous tissues(0.27±0.14)was significantly lower compared with benign breast lesions tissues(0.64±0.17)(P<0.05).Methylation of NF2 was correlated negatively with NF2 expression in breast cancer tissues.(Spearman's r=-0.314,P<0.05).Conclusions:The aberrant promoter methylation of NF2 gene is a frequent molecular pathological event in breast cancer.NF2 mRNA expression is down regulated when the promoter is hypermethylated.
出处 《现代生物医学进展》 CAS 2009年第24期4708-4711,共4页 Progress in Modern Biomedicine
基金 Sci-Tech Support Program of Qingdao(NO.09-1-1-8-nsh)~~
关键词 NF2 DNA甲基化 乳腺癌 基因表达 NF2 DNA methylation Breast cancer Gene expression
  • 相关文献

参考文献12

  • 1徐国茂.CpG岛甲基化和人类肿瘤[J].中国药业,2008,17(9):78-80. 被引量:6
  • 2张丽丽,吴建新.DNA甲基化——肿瘤产生的一种表观遗传学机制[J].遗传,2006,28(7):880-885. 被引量:54
  • 3Yaegashi S,Sachse R,Ohuchi N,et al.Low incidence of nucleotide sequence alteration of the neurofibromato-sis2gene in human breast cancers. Japanese Journal of Cancer Research . 1995
  • 4Kanai Y,Tsuda H,Oda T,et al.Analysis of neurofibromatosis2genein human breast and hepatocellular carcinomas. Japanese Journal of Clinical Oncology . 1995
  • 5Iida A KK,Isobe R,Akiyama F,Sakamoto G,Yoshimoto M,Kasumi F,Nakamura Y,Emi M.Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes and Cancer . 1998
  • 6Lomas J,Bello MJ,Arjona D, et al.Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes and Cancer . 2005
  • 7van Tilborg AA,Morolli B,Giphart-Gassler M,et al.Lack of genetic and epigenetic changes in meningiomas without NF2 loss. Journal of Paleopathology . 2006
  • 8Tomoyo Okada,Liru You,Filippo G Giancotti.Shedding light on Merlin’s wizardry. Trends in Cell Biology . 2007
  • 9Tomoyo Okada,Liru You,Filippo G Giancotti.Shedding light on Merlin’s wizardry. Trends in Cell Biology . 2007
  • 10Yi C,Wilker EW,Yaffe MB,et al.Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2. Cancer Research . 2008

二级参考文献43

  • 1Kawasaki H,Taira K.Induction of DNA methylation and gene silencing by short interfering RNAs in human cells.Nature,2004,431 (7005):212~217.
  • 2Bao N,Lye K W,Barton M K.Micro RNA binding sites in Arabidopsis class Ⅲ HD-ZIP mRNAs are required for methylation of the template chromosome.Dev Cell,2004,7(5):653~662.
  • 3Peter A J,Daiya T.The role of DNA methylation in mammalian epigenetics.Science,2001,293(5532):1068~1070.
  • 4Ichimura T,Watanabe S,Sakamoto Y,Aoto T,Fujita N,Nakao M.Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins.J Biol Chem,2005,280(14):13928 ~ 13935.
  • 5Paz M F,Fraga M F,Avila S,Guo M,Pollan M,Herman J G,Esteller M.A systematic profile of DNA methylation in human cancer cell lines.Cancer Res,2003,63(5):1114~1121.
  • 6Yang B,Guo M,Herman J G,Clark D P.Aberrant promoter methylation profiles of tumor suppressor genes in heaptocellular carcinoma.Am J Pathol,2003,163(3):1101 ~ 1107.
  • 7Matsuda Y,Ichida T,Matsuzawa J,Sugimura K,Asakura H.CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.Cancer Res,2005,65(3):828~834.
  • 8Toyota M,Ahuja N,Ohe-Toyota M,Herman J G,Baylin S B,Issa J P.CpG island methylator phenotype in colorectal cancer.Proc Natl Acad Sci USA,1999,99(15):8681~8686.
  • 9Herman J G,Umar A,Polyak K,Graff J R,Ahuja N,Issa J P,Markowitz S,Willson J K,Hamilton S R,Kinzler K W,Kane M F,Kolodner R D,Vogelstein B,Kunkel T A,Baylin S B.Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.Proc Natl Acad Sci USA,1998,95(12):6870 ~6875.
  • 10veigl M L,Kasturi L,Olechnowicz J,Ma A H,Lutterbaugh J D,Periyasamy S,Li G M,Drummond J,Modrich P L,Sedwick W D,Markowitz S D.Biallelic inactivation of hMLH1 by epigenetic gene silencing,a novel mechanism causing human MSI cancers.Proc Natl Acad Sci USA,1998,95(15):8698~8702.

共引文献58

同被引文献19

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部